High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$98K
$98,128
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APLS
S
Apellis Pharmaceuticals, Inc.
Baumal Caroline
• Officer • Chief Medical Officer
Sell to Cover
2026-01-22
$60,878
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-01-22 | $60,878 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Baumal Caroline
• Officer • Chief Medical Officer
Sell to Cover
2026-01-20
$37,250
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-01-20 | $37,250 | S | Form 4 |